Fusilev

Spectrum’s Fusilev Doesn’t Face Threat From Generics, CEO Shrotriya Says Q
Bloomberg
Sat, 12/10/11 - 12:38 pm
Fusilev
Spectrum Pharmaceuticals
generics
colon cancer
Spectrum Pharmaceuticals Gets Lift from FDA Action On One Of Its Cancer Treatments
Forbes
Sat, 12/3/11 - 03:50 pm
Spectrum Pharmaceuticals
Zevalin
non-Hodgkin's lymphoma
osteosarcoma
Fusilev
A Mea Culpa: Spectrum's Fusilev Sales Are Growing Faster Than I Expected
TheStreet.com
Sat, 10/29/11 - 12:50 pm
Spectrum Pharmaceuticals
Fusilev
colon cancer
Spectrum Solidifies Long-Term Potential
Seeking Alpha
Thu, 09/22/11 - 08:28 am
Spectrum
Fusilev
colorectal cancer
Spectrum's Fusilev Supply Edge Easing
TheStreet.com
Tue, 06/21/11 - 11:04 am
Fusilev
Spectrum Pharmaceuticals
leucovorin
colon cancer
Teva Pharmaceuticals
A Long Term Buying Opportunity in Spectrum Pharmaceuticals Is Forming
Seeking Alpha
Sun, 05/1/11 - 04:21 pm
Spectrum Pharmaceuticals
Fusilev
colorectal cancer
Spectrum Pharma: Fusilev Bubble Will Burst
TheStreet.com
Fri, 04/29/11 - 11:16 am
Fusilev
Spectrum Pharmaceuticals
colon cancer
Teva Positioned to Acquire Spectrum Pharmaceuticals After Fusilev Approval
Seeking Alpha
Thu, 04/28/11 - 09:42 am
Teva Pharmaceuticals
Spectrum Pharmaceuticals
Fusilev
M&A
Spectrum Pharmaceuticals: Pending Approvals Could Send This Stock Flying
Seeking Alpha
Mon, 04/25/11 - 09:19 am
Spectrum Pharmaceuticals
Fusilev
osteosarcoma
Spectrum's Upcoming Catalysts Make It an Attractive Pick
Seeking Alpha
Thu, 04/14/11 - 12:00 pm
Spectrum Pharmaceuticals
Fusilev
FDA Likely to Approve Spectrum Pharma's Cancer Drug After Second Look
Seeking Alpha
Wed, 02/16/11 - 11:27 am
FDA
Fusilev
Spectrum Pharmaceuticals
Teva Pharmaceuticals
colorectal cancer
Spectrum Pharma files Fusilev sNDA with FDA
Pharmaceutical Business Review
Tue, 01/4/11 - 10:06 am
Spectrum Pharmaceuticals
Fusilev
FDA
sNDA
colorectal cancer
Biotech Calendar: FDA Drug Approvals in 2011
TheStreet.com
Mon, 12/13/10 - 12:26 pm
MannKind
Afrezza
Alimera
pSivida
Seattle Genetics
brentuximab vedotin
Illuvien
AstraZeneca
Zictifa
Clinical Data
Vilazodone
Orexigen
Contrave
Bristol-Myers Squibb
Yervoy
Pfizer
Protalix BioTherapeutics
UPLYSO
Xiafaxan
Salix
Human Genome Sciences
Benlysta
Dendreon
Provenge
InterMune
Esbriet
Cell Therapeutics
pixantrone
Forest Labs
Daxas
MELA Sciences
MelaFind
XenoPort
GSK
Horizant
Spectrum Pharmaceuticals
Fusilev
Adventrx
Vertex Pharmaceuticals
Telaprevir
Good News for Spectrum Pharma
Yahoo/Zacks.com
Wed, 12/1/10 - 07:21 am
Spectrum Pharmaceuticals
Fusilev
Pfizer
Sanofi
colorectal cancer
Spectrum expects FDA ruling on Fusilev by April 29
Yahoo/AP
Mon, 11/29/10 - 01:42 pm
FDA
Spectrum Pharmaceuticals
Fusilev
colon cancer
Spectrum Pharmaceuticals says FDA doesn't approve Fusilev for colon cancer, recommends meeting
Yahoo/AP
Fri, 10/9/09 - 09:59 am
Fusilev
FDA
colon cancer
Spectrum Pharmaceuticals
Spectrum Pharmaceuticals: Undervalued Growth Company with Strong Late-Stage Pipeline
Seeking Alpha
Fri, 06/19/09 - 09:01 am
Spectrum Pharmaceuticals
pipelines
Fusilev
Eoquin
Spectrum Pharmaceuticals Announces That FDA Has Accepted FUSILEV sNDA for Colorectal Cancer Indication
Yahoo
Thu, 03/26/09 - 07:51 am
Spectrum Pharmaceuticals
Fusilev
colon cancer
sNDA
FDA

Pages